| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |